YIDU TECH (02158) repurchased nearly 2.3 million Hong Kong dollars on the 26th, accumulating more than 74 million Hong Kong dollars in repurchases within a month.

On February 26, YIDU TECH (02158) once again made a buyback move, repurchasing 382,000 shares at a price of approximately HK$5.97 per share, with a total expenditure of nearly HK$2.3 million. Following this buyback, the company has completed 18 buybacks since January 26 this year, with a total expenditure of over HK$74 million, continuing to demonstrate long-term confidence in its own development and the AI medical field through capital actions. The continuous progress of the buyback is inseparable from the steady implementation of business innovation and the breakthrough of core projects. In terms of news, according to media reports, the clinical evidence-based intelligent body "MediRec" developed by YIDU TECH has entered the internal testing phase. This mini-program is designed for clinical doctors and medical researchers, focusing on the real needs of doctors in clinical diagnosis and treatment as well as scientific research, and is inviting frontline clinical doctors to experience and create together. Also worth noting, the National Data Bureau recently officially released the "2025 'Data Element ' National Finals Award-winning Project Case Collection". The "Hainan Free Trade Port 'External Defense Input' Infectious Disease Monitoring and Early Warning" project, led by the Hainan Provincial Health Commission Statistics Information Center and supported by YIDU TECH's core technology, was selected as an outstanding practical case in the medical and health field.